Страна: Ирландия
Язык: английский
Источник: HPRA (Health Products Regulatory Authority)
Butorphanol tartrate
V.M.D. n.v.,
QN02AF01
Butorphanol tartrate
10 milligram(s)/millilitre
Solution for injection
POM: Prescription Only Medicine as defined in relevant national legislation
butorphanol
Authorised
2009-09-04
1. NAME OF THE VETERINARY MEDICINAL PRODUCT Alvegesic vet. 10 mg/ml, Solution for injection for Horses, Dogs and Cats 2. QUALITATIVE AND QUANTITATIVE COMPOSITION Each ml contains: ACTIVE SUBSTANCE: Butorphanol 10 mg (equivalent to butorphanol tartrate 14.58 mg) EXCIPIENTS: QUALITATIVE COMPOSITION OF EXCIPIENTS AND OTHER CONSTITUENTS QUANTITATIVE COMPOSITION IF THAT INFORMATION IS ESSENTIAL FOR PROPER ADMINISTRATION OF THE VETERINARY MEDICINAL PRODUCT_ _ Benzethonium chloride 0.10 mg Citric acid monohydrate Sodium citrate Sodium chloride Water for injections Clear, colourless solution. 3. CLINICAL INFORMATION 3.1 TARGET SPECIES Horses, Dogs, Cats. 3.2 INDICATIONS FOR USE FOR EACH TARGET SPECIES HORSE As an analgesic: For relief of moderate to severe abdominal pain (alleviates abdominal pain associated with colic of gastrointestinal origin). As a sedative: For sedation after the administration of certain alpha2-adrenoceptor agonists (detomidine, romifidine). DOG As an analgesic: For relief of moderate visceral pain. As a sedative: For sedation in combination with certain alpha2-adrenoceptor agonists (medetomidine). As a pre-anaesthetic: For pre-anaesthesia as sole agent and in combination with acepromazine. As an anaesthetic: For anaesthesia in combination with medetomidine and ketamine. CAT As an analgesic for the relief of moderate pain: For pre-operative analgesia in combination with acepromazine/ketamine or xylazine/ketamine. For post- operative analgesia after small surgical procedures. As a sedative: For sedation in combination with certain alpha2-adrenoceptor agonists (medetomidine). As an anaesthetic: For anaesthesia in combination with medetomidine and ketamine. 3.3 CONTRAINDICATIONS Do not use in cases of hypersensitivity to the active substance or to any of the excipients. Do not use in animals with severe dysfunction of the liver or kidneys. Use of butorphanol is contraindicated in case of cerebral injury or organic brain lesions and in animals with obstructive respiratory disease, heart dysfunction or Прочитать полный документ